
    <html>
    <head><title>CRON.TO</title>
<style>
body {
  font-family: Arial, sans-serif;
  margin: 20px;
}
.container {
  display: grid;
  grid-template-columns: 50% 50%;
  grid-template-rows: auto auto;
  gap: 20px;
}
img {
  width: 100%;
  height: auto;
  max-height: 400px;
  border: 1px solid #ccc;
  object-fit: contain;
}

.cell {
  padding: 10px;
}
.table-scroll {
  max-height: 400px;
  overflow-y: auto;
  border: 1px solid #aaa;
}
table {
  width: 100%;
  border-collapse: collapse;
}
th, td {
  border: 1px solid #aaa;
  padding: 5px;
  text-align: left;
  font-size: 14px;
}
.negative {
  background: linear-gradient(to right, #ffdddd, white);
}
.positive {
  background: linear-gradient(to right, white, #ddffdd);
}
.pos-light  { background: #e6ffe6; }  
.pos-mid    { background: #99ff99; }  
.pos-strong { background: #33cc33; }   

.neg-light  { background: #ffe6e6; }   
.neg-mid    { background: #ff9999; }   
.neg-strong { background: #ff3333; }   

h2 { border-bottom: 2px solid #444; }
<script>
function toggleText(id) {
  const moreText = document.getElementById(id);
  const btn = document.getElementById(id + "_btn");

  if (moreText.style.display === "none") {
    moreText.style.display = "inline";
    btn.innerText = " Show less";
  } else {
    moreText.style.display = "none";
    btn.innerText = " Show more";
  }
}
</script>
</style>
</head>
    <body>
    <h2><span style='color:#1e66f5; font-weight:900; margin-right:10px;'>quarterly earnings d</span> CRON.TO  
        <span style='font-weight:normal; font-size: 18px;'>(41d - Regulatory changes)</span>
        <span style='color:darkred; font-weight:bold; font-size: 20px;'> 23D NEG</span>
        <a href='https://finance.yahoo.com/chart/CRON.TO?interval=1mo' target='_blank'>Yahoo</a>
        <span style='font-weight:600;'>  bought (2.73-3.03) —  — now: 3.35</span>
    </h2>

    <div class="container">
        <div class="cell"><div style='display:flex; gap:10px; align-items:flex-start'>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/C_ZOOM_CRON.TO_NEWS.jpg' target='_blank'>    <img src='C_ZOOM_CRON.TO_NEWS.jpg' alt='C_ZOOM_CRON.TO_NEWS.jpg'></a></div>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/C_CRON.TO_BAND.jpg' target='_blank'>    <img src='C_CRON.TO_BAND.jpg' alt='C_CRON.TO_BAND.jpg'></a></div></div></div>
        <div class="cell"><div style='display:flex; gap:10px; align-items:flex-start'>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/B_ZOOM_CRON.TO_ALL.jpg' target='_blank'>    <img src='B_ZOOM_CRON.TO_ALL.jpg' alt='B_ZOOM_CRON.TO_ALL.jpg'></a></div>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/B_CRON.TO_BAND.jpg' target='_blank'>    <img src='B_CRON.TO_BAND.jpg' alt='B_CRON.TO_BAND.jpg'></a></div></div></div>
        <div class="cell"><div style='display:flex;gap:10px;align-items:flex-start'><a href="https://vosorin.github.io/100__2025_06_public/RAPORT/A_CRON.TO_23d_neg_ZOOM.png" target="_blank"><img src="A_CRON.TO_23d_neg_ZOOM.png" alt="A_CRON.TO_23d_neg_ZOOM.png"></a><a href="https://vosorin.github.io/100__2025_06_public/RAPORT/A_CRON.TO_23d_neg.jpg" target="_blank"><img src="A_CRON.TO_23d_neg.jpg" alt="A_CRON.TO_23d_neg.jpg"></a></div></div>
        <div class="cell"><div class='table-scroll'><table><tr><th>Date</th><th>Score</th><th>AMR</th><th>Type</th><th>Summary</th><th>Links</th></tr><tr class='pos-light'><td>2025-11-11</td><td>0.20</td><td></td><td>regulatory change</td><td>0.2 local feel              __   CRON.TO __    -> i:0.2<-                      <br><br>FEELING: total score: +0.2 --- <br> - Trump’s recent posts hint at possible Medicare CBD coverage and stricter hemp rules, sparking a temporary rally in major cannabis stocks. While optimism is high, the market remains cautious as policy clarity is still pending; investors should monitor regulatory developments and stock volatility. <br><br>*** REZUMAT *** - Trump posted video supporting CBD Medicare coverage, triggering 42% jump in Tilray, 25% in Aurora, 18% in Canopy. - Stocks returned to pre‑Trump levels after initial rally. - Potential 2018 Farm Bill updates expected by year‑end, adding federal hemp standards. - Investor optimism dubbed “Trump effect” but policy clarity still pending. - Federal regulation could unlock billions in cannabis growth, but volatility remains.   (gpt-oss:20b on 2025-11-11 21:32:15)</td><td><a href='https://www.benzinga.com/personal-finance/management/25/11/48783637/we-could-be-looking-at-a-true-inflection-point-for-cannabis-optimism-surges-among-investors-thanks-to-the-trump-effect' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-11-11</td><td>-0.30</td><td></td><td>regulatory change</td><td>-0.30 GPT4 / -1.00 local feel              __   CRON.TO __    -> i:0.3<-                      <br><br>FEELING: -0.3 --- <br> - Regulatory crackdown threatens hemp sector; cannabis stocks remain cautious; potential upside if federal reform materializes; short‑term volatility likely. <br><br>*** REZUMAT *** - Capitol Hill bill caps hemp THC at 0.4 mg, could eliminate 95% of businesses, wiping out $28 B market. - Senate rejected Rand Paul amendment; Trump backs crackdown, citing safety and competition. - Virginia and New Jersey elections elect pro‑cannabis leaders, boosting East Coast legalization momentum. - Green Thumb Industries workers unionize after 45‑day strike, securing better wages and benefits. - U.S. cannabis market projected to triple to $148 B by 2035. - Oklahoma adult‑use ballot fails; market likely remains medical‑only for now. - Cannabis stocks see high volume but flat prices; TLRY, CGC, CRON unchanged.   <br> <br>-- GPT4: -0.3, Hold, Regulatory crackdown pressures sector; short-term volatility expected.   (GPT4o +++ gpt-oss:20b on 2025-11-11 21:35:19)</td><td><a href='https://cannatechtoday.com/last-week-in-weed-november-4-11/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-07</td><td>0.20</td><td></td><td>quarterly earnings</td><td>0.2 local feel              __   CRON.TO __    -> i:0.2<-                      <br><br>FEELING: total score 0.2 --- <br> - Cronos Group sees fresh institutional buying, but a consensus sell rating and modest earnings beat suggest caution; potential upside limited until clearer fundamentals emerge. <br><br>*** REZUMAT *** - Bastion Asset Management bought 310,544 shares (~$619k), 0.08% stake in Q2. - Envestnet, Chicago Partners, International Assets, Mraz Amerine each added ~$33‑57k positions in Q2. - Goldman Sachs lifted 84.6% to 1,076,405 shares ($1.948M) in Q1. - Institutional ownership stands at 8.71% of CRON shares. - Stock opened at $2.47; 1‑yr low $1.60, high $3.16; market cap $945.74M. - Q earnings: $0.07 EPS vs $0.02 estimate; net margin 14.19%; revenue $36.34M. - Analysts maintain a consensus "Sell" rating; some hold upgrades noted.   (gpt-oss:20b on 2025-11-09 02:01:31)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-bastion-asset-management-inc-purchases-new-position-in-cronos-group-inc-cron-2025-11-07/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-06</td><td>0.20</td><td></td><td>quarterly earnings</td><td>0.2 local feel              __   CRON.TO __    -> i:0.2<-                      <br><br>FEELING: total score: 0.2 --- <br> - Cronos shows strong Q3 earnings and cash position, but valuation and Canadian supply constraints temper upside; hold recommendation. <br><br>*** REZUMAT *** - Q3 2025: record net revenue, gross profit, Adjusted EBITDA driven by Israel performance and cost control. - Cash & investments: $824M, supporting global expansion and innovation. - Canadian supply constraints temporary; GrowCo expanding cultivation capacity to offset. - Analyst consensus: Hold with C$4.00 price target; Spark rates Neutral. - Positive outlook: revenue growth, improved margins; technical indicators lack momentum, high P/E. - Market cap C$1.33B, avg volume 200,980, technical sentiment Buy.   (gpt-oss:20b on 2025-11-07 02:41:18)</td><td><a href='https://www.tipranks.com/news/company-announcements/cronos-group-achieves-record-q3-2025-results-strengthens-global-position' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-06</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CRON.TO __    -> i:0.3<-                      <br><br>FEELING: total score: +0.3 --- <br> - Cronos Q3 2025 shows record revenue, strong margins, and a robust cash position, supporting growth and shareholder value, though Canadian flower supply constraints may temper near‑term expansion. <br><br>*** REZUMAT *** - Net revenue Q3 2025 $36.3 M, up 9% QoQ, 6% YoY, record in Israel. - Gross profit $18.3 M, up 14.7 M YoY, margin 50%. - Adjusted EBITDA $5.7 M, up 11.7 M YoY. - Net income $28.3 M, up 21 M YoY. - Cash & equivalents $824 M, debt‑free balance sheet. - PEACE NATURALS leads Israel, record sales volume. - Spinach brand #2 in Canada, 19.7% edible share. - GrowCo expansion unlocks additional flower capacity for 2026. - Canadian flower supply constraints limit growth potential. - Q3 2025 results driven by Israel mix shift.   (gpt-oss:20b on 2025-11-07 02:45:42)</td><td><a href='https://www.globenewswire.com/news-release/2025/11/06/3182461/0/en/Cronos-Group-Reports-2025-Third-Quarter-Results.html' target='_blank'>Link</a></td></tr></table></div></div>
    </div>
    </body>
    </html>
    